Sanjiv S. Agarwala, MD | Authors


Combining HDAC Inhibitors With Immunotherapy in Melanoma

September 07, 2018

Sanjiv S. Agarwala, MD, chairman of medical oncology at St. Luke’s University Health Network, discusses the combination of immunotherapy and a histone deacetylase inhibitor in patients with melanoma, as well as other types of cancer.